Jump to main content
Jump to site search

Issue 4, 2020
Previous Article Next Article

Reversing binding sensitivity to A147T translocator protein

Author affiliations

Abstract

The translocator protein (TSPO) is a target for the development of neuroinflammation imaging agents. Clinical translation of TSPO PET ligands, such as [11C]DPA-713, has been hampered by the presence of a common polymorphism (A147T TSPO), at which all second-generation TSPO ligands lose affinity. Little is known about what drives binding at A147T compared to WT TSPO. This study aimed to identify moieties in DPA-713, and related derivatives, that influence binding at A147T compared to WT TSPO. We found changes to the nitrogen position and number in the heterocyclic core influences affinity to WT and A147T to a similar degree. Hydrogen bonding groups in molecules with an indole core improve binding at A147T compared to WT, a strategy that generated compounds that possess up to ten-times greater affinity for A147T. These results should inform the future design of compounds that bind both A147T and WT TSPO for use in neuroinflammation imaging.

Graphical abstract: Reversing binding sensitivity to A147T translocator protein

Back to tab navigation

Supplementary files

Article information


Submitted
16 Dec. 2019
Accepted
22 Febr. 2020
First published
12 Marts 2020

RSC Med. Chem., 2020,11, 511-517
Article type
Research Article

Reversing binding sensitivity to A147T translocator protein

S. V. Vo, S. D. Banister, I. Freelander, E. L. Werry, T. A. Reekie, L. M. Ittner and M. Kassiou, RSC Med. Chem., 2020, 11, 511
DOI: 10.1039/C9MD00580C

Social activity

Search articles by author

Spotlight

Advertisements